Vicarious Surgical Inc.
Close on Oct 19, 2026
- Market cap
- $134.10K
- P/E (TTM)
- –
- Dividend yield
- –
About Vicarious Surgical
Orthopedic, Prosthetic & Surgical Appliances & Supplies, SIC 3842
Vicarious Surgical Inc. is a medical technology company developing miniaturized robotic systems designed to perform minimally invasive surgery. Its core product candidate, the Vicarious Surgical System, is a single-port surgical robot featuring decoupled actuators, stereoscopic visualization, and sensor-equipped instrument arms that provide human-equivalent motion inside the abdominal cavity. The platform is engineered to enter the abdomen through an incision as small as 1.8 centimeters to support procedures such as ventral hernia repair, as well as gynecological and gastrointestinal interventions. The system's intended customers include hospitals and ambulatory surgical centers seeking flexible, mobile alternatives to conventional multi-port or bulky surgical robotics.
The company operates as a development-stage enterprise focused on engineering and pre-submission regulatory activities. Its system components include a mobile patient cart capable of moving through standard facility doorways, along with a dedicated surgeon console. Vicarious Surgical Inc. maintains its principal executive offices and headquarters in Waltham, Massachusetts.
Summary of the business section of Vicarious Surgical's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Vicarious Surgical Inc.
- Founded
- 2020
- Headquarters
- Waltham, MA
- Address
- 78 Fourth Avenue 02451
- Phone
- (617) 868-1700
- Employees
- 26, Dec 31, 2025
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
- Auditor
- Cherry Bekaert LLP, Raleigh, North Carolina
Stock & identifiers
- Ticker
- RBOT
- Exchange
- OTC
- IPO date
- Jul 16, 2020
- Shares outstanding
- 7M, Apr 27, 2026
- Public float
- $38.80M, Jun 30, 2025
- Filer category
- <br>Emerging growth company
- Stock splits
- 1-for-30 reverse, Aug 13, 2024; 1-for-30 reverse, Jun 13, 2024
- SEC CIK
- 1812173
- CUSIP
- 92561V208
- ISIN
- US92561V2088
- EIN
- 00-0000000
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Adam David Sachs | President, Director | 11,286,006 |
| Sammy Khalifa | Chief Technology Officer, Director | 4,548,129 |
| Stephen From | Chief Executive Officer, Director | – |
| Sarah Romano | Chief Financial Officer | – |
| John Mazzola | Chief Operating Officer | 9,498 |
| William John Kelly | CFO and Treasurer | 12,241 |
| Joseph Edward Doherty | Director | – |
| Donald F. Tang | Director | 40,425 |
| David D. Ho | Director | 373,661 |
| Fuad Ahmad | Director | – |
| Beverly A. Huss | Director | 250,917 |
| Randolph A. Clark | Director | – |
Employees
Headcount reported in annual reports
“As of March 9, 2026, we had 26 employees,”
Corporate history
Events identified from SEC filings